Exploring new interregional opportunities for pharmaceutical supply chains : the potential of Mercosur countries to advance the EU's Global Health Strategy / Fernanda Cimini, Michael Bayerlein, Pedro A. Villarreal and Franziska Schwebel ; Stiftung Wissenschaft und Politik - German Institute for International and Security Affairs
The European Union’s (EU) Global Health Strategy calls for open and strategic autonomy in the field of pharmaceuticals, which would lead to the redesign of EU global supply and value chains as well as trade relations. As the EU and Germany are seeking to diversify their trade partners, the Mercosur countries offer latent potential. Mercosur is the name of the South American trade bloc consisting of Argentina, Brazil, Paraguay and Uruguay, with Venezuela’s membership currently suspended. The associate states of the bloc are Chile, Peru, Colombia, Ecuador, Guyana and Suriname. Bolivia is currently awaiting final approval to become a full member of the bloc..
Medienart: |
E-Book |
---|
Erscheinungsjahr: |
[February 2024] |
---|---|
Erschienen: |
Berlin: SWP ; February 2024 |
Reihe: |
SWP comment - 2024, no. 5 (February 2024) |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Salles, Fernanda Cimini [VerfasserIn] |
---|---|
Körperschaft: |
Stiftung Wissenschaft und Politik [Herausgebendes Organ] |
Links: |
doi.org [kostenfrei] |
---|
Anmerkungen: |
Gesehen am 16.02.2024 |
---|
Umfang: |
1 Online-Ressource (8 Seiten) ; 1 Illustration |
---|
doi: |
10.18449/2024C05 |
---|---|
Weitere IDs: |
urn:nbn:de:101:1-2024030119250301445509 urn:nbn:de:0168-ssoar-93855-2 10419/284705 |
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1881024911 |
---|
LEADER | 01000cam a2200265 4500 | ||
---|---|---|---|
001 | 1881024911 | ||
003 | DE-627 | ||
005 | 20240426091357.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240216s2024 gw |||||o 00| ||eng c | ||
024 | 7 | |a urn:nbn:de:101:1-2024030119250301445509 |2 urn | |
024 | 7 | |a urn:nbn:de:0168-ssoar-93855-2 |2 urn | |
024 | 7 | |a 10.18449/2024C05 |2 doi | |
024 | 7 | |a 10419/284705 |2 hdl | |
035 | |a (DE-627)1881024911 | ||
035 | |a (DE-599)KXP1881024911 | ||
035 | |a (OCoLC)1425248251 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
044 | |c XA-DE-BE | ||
082 | 0 | 4 | |a 330 |q DE-101 |
084 | |a RA01.01 |2 fivr | ||
084 | |a RD04.03 |2 fivr | ||
084 | |a SD02 |2 fivs | ||
084 | |a SG03.02 |2 fivs | ||
100 | 1 | |a Salles, Fernanda Cimini |e verfasserin |0 (DE-588)1156854687 |0 (DE-627)1019794054 |0 (DE-576)502468548 |4 aut | |
245 | 1 | 0 | |a Exploring new interregional opportunities for pharmaceutical supply chains |b the potential of Mercosur countries to advance the EU's Global Health Strategy |c Fernanda Cimini, Michael Bayerlein, Pedro A. Villarreal and Franziska Schwebel ; Stiftung Wissenschaft und Politik - German Institute for International and Security Affairs |
264 | 1 | |a Berlin |b SWP |c [February 2024] | |
300 | |a 1 Online-Ressource (8 Seiten) |b 1 Illustration | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
490 | 1 | |a SWP comment |v 2024, no. 5 (February 2024) | |
500 | |a Gesehen am 16.02.2024 | ||
520 | |a The European Union’s (EU) Global Health Strategy calls for open and strategic autonomy in the field of pharmaceuticals, which would lead to the redesign of EU global supply and value chains as well as trade relations. As the EU and Germany are seeking to diversify their trade partners, the Mercosur countries offer latent potential. Mercosur is the name of the South American trade bloc consisting of Argentina, Brazil, Paraguay and Uruguay, with Venezuela’s membership currently suspended. The associate states of the bloc are Chile, Peru, Colombia, Ecuador, Guyana and Suriname. Bolivia is currently awaiting final approval to become a full member of the bloc. | ||
610 | 2 | 7 | |0 (DE-588)5098525-5 |0 (DE-627)132918269 |0 (DE-576)194702391 |a Europäische Union |2 gnd |
650 | 4 | |a pharmaceutical supply chains |7 (dpeaa)DE-206 | |
650 | 4 | |a Mercosur countries |7 (dpeaa)DE-206 | |
650 | 4 | |a EU’s Global Health Strategy |7 (dpeaa)DE-206 | |
650 | 4 | |a Argentina |7 (dpeaa)DE-206 | |
650 | 4 | |a Brazil |7 (dpeaa)DE-206 | |
650 | 4 | |a Paraguay |7 (dpeaa)DE-206 | |
650 | 4 | |a Uruguay |7 (dpeaa)DE-206 | |
650 | 4 | |a Chile |7 (dpeaa)DE-206 | |
650 | 4 | |a Peru |7 (dpeaa)DE-206 | |
650 | 4 | |a Colombia |7 (dpeaa)DE-206 | |
650 | 4 | |a Ecuador |7 (dpeaa)DE-206 | |
650 | 4 | |a Guyana |7 (dpeaa)DE-206 | |
650 | 4 | |a Suriname |7 (dpeaa)DE-206 | |
650 | 4 | |a Bolivia |7 (dpeaa)DE-206 | |
650 | 4 | |a free trade agreement (FTA) |7 (dpeaa)DE-206 | |
650 | 4 | |a European Medicines Agency (EMA) |7 (dpeaa)DE-206 | |
650 | 4 | |a Health Emergency Preparedness and Response Authority (HERA) |7 (dpeaa)DE-206 | |
700 | 1 | |a Bayerlein, Michael |e verfasserin |0 (DE-588)1213311500 |0 (DE-627)1703850084 |4 aut | |
700 | 1 | |a Villarreal, Pedro A. |d 1984- |e verfasserin |0 (DE-588)1145310311 |0 (DE-627)1005543925 |0 (DE-576)474966119 |4 aut | |
700 | 1 | |a Schwebel, Franziska |e verfasserin |0 (DE-588)1319589618 |0 (DE-627)1881025640 |4 aut | |
710 | 2 | |a Stiftung Wissenschaft und Politik |e Herausgebendes Organ |0 (DE-588)2023076-X |0 (DE-627)102119678 |0 (DE-576)191759279 |4 isb | |
775 | 0 | 8 | |i Übersetzt als |a Salles, Fernanda Cimini |t Der Mercosur als möglicher Partner der EU bei pharmazeutischen Lieferketten |d Berlin : SWP, 2024 |h 1 Online-Ressource (8 Seiten) |w (DE-627)1882378253 |
830 | 0 | |a SWP comment |v 2024, no. 5 (February 2024) |9 2024,5 |w (DE-627)1748199498 |w (DE-576)385511523 |w (DE-600)3053616-9 |x 2747-5107 |7 ns | |
856 | 4 | 0 | |u https://doi.org/0.18449/2024C05 |x Resolving-System |z kostenfrei |
856 | 4 | 0 | |u https://www.swp-berlin.org/publications/products/comments/2024C05_PharmaceuticalsSupply.pdf |q application/pdf |x Verlag |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://hdl.handle.net/10419/284705 |x Resolving-System |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.18449/2024C05 |x Resolving-System |z kostenfrei |
856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:101:1-2024030119250301445509 |x Resolving-System |z kostenfrei |
856 | 4 | 0 | |u https://d-nb.info/1322277915/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |
856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:0168-ssoar-93855-2 |x Resolving-System |z kostenfrei |
912 | |a GBV_ILN_26 | ||
912 | |a ISIL_DE-206 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a GBV_ILN_2403 | ||
912 | |a ISIL_DE-LFER | ||
912 | |a GBV_ILN_2470 | ||
912 | |a ISIL_DE-615 | ||
912 | |a ISIL_DE-B1567 | ||
936 | f | i | |0 (DE-627)1756131406 |a RA01.01 |b EU/EG sowie Mitgliedsländer |k Europa |k Europäische Organisationen |k EU/EG sowie Mitgliedsländer |2 fivr |
936 | f | i | |0 (DE-627)1756132739 |a RD04.03 |b MERCOSUR |k Lateinamerika |k Südamerika |k MERCOSUR |2 fivr |
936 | f | i | |0 (DE-627)1756135541 |a SD02 |b Internationale Wirtschaftsbeziehungen/Wirtschaftszusammenarbeit |k Internationale Wirtschaft/Außenwirtschaft |k Internationale Wirtschaftsbeziehungen/Wirtschaftszusammenarbeit |2 fivs |
936 | f | i | |0 (DE-627)1756136017 |a SG03.02 |b Gesundheit |k Gesellschaft |k Sozialpolitik/Soziales |k Gesundheit |2 fivs |
938 | 1 | 0 | |0 (DE-627)132918269 |0 (DE-588)5098525-5 |a Europäische Union |2 gnd |2 fivt |
938 | 1 | 0 | |0 (DE-627)148511430 |0 (DE-588)5100682-0 |a Mercosur |2 gnd |2 fivt |
938 | 1 | 0 | |0 (DE-627)1756148392 |0 (DE-615)6603003 |a Global Health Governance |2 fivt |
938 | 1 | 0 | |0 (DE-627)1756200807 |0 (DE-615)6601791 |a Lieferer-Abnehmer-Beziehungen |2 fivt |
938 | 1 | 0 | |0 (DE-627)1756167885 |0 (DE-615)6609043 |a Pharmazeutische Produkte |2 fivt |
938 | 1 | 0 | |0 (DE-627)1756165300 |0 (DE-615)6601902 |a Apotheke |2 fivt |
938 | 1 | 0 | |0 (DE-627)1756230994 |0 (DE-615)6608720 |a Gesundheitswesen |2 fivt |
938 | 1 | 0 | |0 (DE-627)1756233012 |0 (DE-615)6601174 |a Gesundheitshilfe |2 fivt |
938 | 1 | 0 | |0 (DE-627)175618058X |0 (DE-615)6606163 |a Gesundheitshilfe (Auslandshilfe) |2 fivt |
951 | |a BO | ||
980 | |2 26 |1 01 |x 0206 |b 4497166066 |c 08 |f --%%-- |d DSP 386 |e --%%-- |j --%%-- |y z1z |z 07-03-24 | ||
980 | |2 2403 |1 01 |x DE-LFER |b 4497065464 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 07-03-24 | ||
980 | |2 2470 |1 01 |x DE-615 |b 4485811484 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |h EDNB-202402 |y l01 |z 16-02-24 | ||
980 | |2 2470 |1 02 |x DE-B1567 |b 4486938704 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |y l02 |z 17-02-24 | ||
981 | |2 2403 |1 01 |x DE-LFER |r https://doi.org/0.18449/2024C05 | ||
981 | |2 2403 |1 01 |x DE-LFER |r https://www.swp-berlin.org/publications/products/comments/2024C05_PharmaceuticalsSupply.pdf | ||
995 | |2 2470 |1 01 |x DE-615 |a EDNB-202402 | ||
998 | |2 2470 |1 01 |x DE-615 |0 2024-02-29 |